Tag Archives: Could

Precious metal flecks could be catalyst for better cancer therapies

Tiny extracts of a precious metal used widely in industry could play a vital role in new cancer therapies. Researchers have found a way to dispatch minute fragments of palladium — a key component in motor manufacture, electronics and the oil industry — inside cancerous cells. Scientists have long known that the metal, used in… Read More »

Optic Nerve Stimulation Device Could Provide Visual Aid for Blind People

Researchers at Ecole Polytechnique Fédérale de Lausanne in Switzerland have developed a new type of intraneural electrode to bypass the eyeball and send messages directly to the brain through the optic nerve. The technique could provide a visual aid for permanently blind people. Using retinal implants to treat blindness is a developing field. The concept… Read More »

Bayer, Elanco could lock up animal health merger next week: report

When rumors emerged nearly a year ago that Bayer might be planning to exit the animal-health business, Eli Lilly spinoff Elanco was not at the top of any market-watcher’s list of potential buyers—especially not after it became clear that several private equity players were interested in the asset. Turns out Elanco was interested, and the… Read More »

Using smart watches to monitor your heart could do more harm than good

Fitness trackers like the Apple Watch now allow you to detect heart conditions such as atrial fibrillation. That’s not always a good thing, says doctor Margaret McCartney Technology | Comment 17 July 2019 Josie Ford By Margaret McCartney SELF-EMPOWERED, self-motivated, self-aware: we have got used to the idea that more knowledge about our health is… Read More »

AMAG wins FDA nod for Vyleesi. Could it be the ‘female Viagra’ that Addyi never was?

Valeant, now Bausch Health, paid $ 1 billon in 2015 for Sprout Pharmaceuticals’ female libido drug Addyi, only to sell it back in 2017. Now as the drug is still nowhere near the blockbuster status Valeant once touted, a rival has arrived. The FDA late Friday approved AMAG Pharmaceuticals’ Vyleesi (bremelanotide) to treat premenopausal women with… Read More »